Agomab Therapeutics NV (AGMB)
Market Open
11 Sep, 15:17
NASDAQ (NMS) NASDAQ (NMS) Primary $
13. 69
-0.25
-1.7934%
$
686.52M Market Cap
- P/E Ratio
- Div Yield
46,814 Volume
- Eps
$ 13.94
Previous Close Analysts:
Want to track AGMB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Agomab Therapeutics NV Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Madelyn D. Purcell Pfizer Inc | 75,000 | $813,750 | $1.01M | $200,250 | 24.61% |
 Regan O'Neill Burkehill Global Management LP | 35,000 | $367,150 | $552,300 | $185,150 | 50.43% |
 Hui Fai Tam Caitong International Asset Management Co. Ltd. | 2 | $26 | $27.37 | $1.37 | 5.27% |
 Raymond Debbane Siren, L.L.C. | 411,250 | $4.31M | $5.8M | $1.49M | 34.51% |
